Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Heart Valve Disease Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Varicose Vein Foam has Promising Results

Ivanhoe Newswire


(Ivanhoe Newswire) -- Varicose veins -- theyre unsightly and down-right irritating. Injectable microfoam has been a standard treatment for spider veins and small varicose veins since 1997. But in Phase II trials, a new kind of foam is proving to be effective and less painful then the current sclerosant foams.

Varisolve, a foam made with carbon dioxide, is relatively painless compared to other sclerosants which can cause burning, John D. Regan, M.D., clinical director of the Interventional Section in the Department of Radiology at Wake Forest University Baptist Medical Center and presenting author of the trial, was quoted as saying.

Text Continues Below



Manufacturers say the Varisolve foam injection is less invasive than traditional laser treatments. It is injected into the sphenoid vein using a small catheter. The vein is compressed in the groin to trap the foam in the leg and additional foam is injected. The leg is then put into a compression dressing and stocking, and the patient is finished.

Although any air-based foam carries a theoretical risk to the patient because of the insolubility of air in the blood, the risk is small, Dr. Regan said. He added that based on the preliminary results, We believe that the carbon dioxide-based foam used in Varisolve will be totally safe due to the small size of the bubbles, the consistency of the foam and the solubility of carbon dioxide.

However, patients with a right-to-left shunt in their hearts may be at risk from the foam treatment. According to Dr. Regan, the risk to these patients is that foam bubbles could cross the shunt and go the brain without being filtered in the lungs.

In more than 90 percent of the 28 patients studied so far, tiny bubbles have been detected in the blood during the procedure, but researchers say there have been no visual, cardiac or neurological changes.

Sign up for a free weekly e-mail on Medical Breakthroughs called First to Know by clicking here.

SOURCE: Presented at the Society of Interventional Radiologys 33rd Annual Scientific Meeting, Washington D.C., March 15-20, 2008

 

This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.




Last updated 3/18/2008

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake





New Features

New ADHD Site!


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map